Show simple item record

dc.contributor.authorRucker, JJHen_US
dc.contributor.authorBreen, Gen_US
dc.contributor.authorPinto, Den_US
dc.contributor.authorPedroso, Ien_US
dc.contributor.authorLewis, CMen_US
dc.contributor.authorCohen-Woods, Sen_US
dc.contributor.authorUher, Ren_US
dc.contributor.authorSchosser, Aen_US
dc.contributor.authorRivera, Men_US
dc.contributor.authorAitchison, KJen_US
dc.contributor.authorCraddock, Nen_US
dc.contributor.authorOwen, MJen_US
dc.contributor.authorJones, Len_US
dc.contributor.authorJones, Ien_US
dc.contributor.authorKorszun, Aen_US
dc.contributor.authorMuglia, Pen_US
dc.contributor.authorBarnes, MRen_US
dc.contributor.authorPreisig, Men_US
dc.contributor.authorMors, Oen_US
dc.contributor.authorGill, Men_US
dc.contributor.authorMaier, Wen_US
dc.contributor.authorRice, Jen_US
dc.contributor.authorRietschel, Men_US
dc.contributor.authorHolsboer, Fen_US
dc.contributor.authorFarmer, AEen_US
dc.contributor.authorCraig, IWen_US
dc.contributor.authorScherer, SWen_US
dc.contributor.authorMcGuffin, Pen_US
dc.date.accessioned2016-12-13T10:52:42Z
dc.date.issued2013-02en_US
dc.date.submitted2016-09-26T16:14:53.214Z
dc.identifier.issn1359-4184en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/18224
dc.description.sponsorshipThis study was funded by a joint grant from the U.K. Medical Research Council and GlaxoSmithKline (G0701420). James Rucker was supported by a fellowship from the Wellcome Trust (086635). Alexandra Schosser was supported by the Erwin-Schroedinger Fellowship (J2647) of the Austrian Science Funds. Alexandra Schosser, Inti Pedroso and Sarah Cohen-Woods received financial support from the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King’s College London. Margarita Rivera was supported by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme. The GENDEP study was funded by a European Commission Framework 6 grant, EC Contract Ref.: LSHBCT-2003-503428 and GlaxoSmithKline contributed by funding an add-on project in the London centre. The population-based study in Lausanne was supported by three grants from the Swiss National Science Foundation (#3200B0-105993, #3200B0-118308, #33CSCO-122661) and from GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery Verona, R&D). Rudolf Uher and Peter McGuffin are supported by a grant from the European Commission (Grant Agreement #115008). Genotyping was performed at the Centre Nationale De Genotypage, Evry, Paris, with acknowledgement to Simon Heath, Ivo Gut and Mark Lathrop. The authors acknowledge the contribution of phase 2 of the Wellcome Trust Case Control Consortium in providing access to control data sets from the 1958 British birth cohort and the national blood service cohort.en_US
dc.format.extent183 - 189en_US
dc.relation.ispartofMOLECULAR PSYCHIATRYen_US
dc.rightsPublished in final edited form as: Mol Psychiatry. 2013 February ; 18(2): 183–189. doi:10.1038/mp.2011.144.
dc.subjectCNVsen_US
dc.subjectdepressionen_US
dc.subjectGWASen_US
dc.titleGenome-wide association analysis of copy number variation in recurrent depressive disorderen_US
dc.typeArticle
dc.identifier.doi10.1038/mp.2011.144en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000316567800010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue2en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume18en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record